Compounds > anastrozole
Page last updated: 2024-10-22

anastrozole and Diffuse Parenchymal Lung Disease

anastrozole has been researched along with Diffuse Parenchymal Lung Disease in 1 studies

Research Excerpts

ExcerptRelevanceReference
"An 83‒year‒old woman received trastuzumab plus anastrozole as first‒line chemotherapy for inflammatory breast cancer in her left breast."8.02[Case Report of an Elderly Patient with Interstitial Pneumonia Caused by the Administration of Trastuzumab plus Anastrozole for the Treatment of Inflammatory Breast Cancer]. ( Aizu, K; Fujieda, H; Furuta, M; Iwata, T; Kageyama, Y; Kobayashi, S; Sato, F; Toyoda, Y; Watanabe, S; Yamaguchi, R, 2021)
"An 83‒year‒old woman received trastuzumab plus anastrozole as first‒line chemotherapy for inflammatory breast cancer in her left breast."4.02[Case Report of an Elderly Patient with Interstitial Pneumonia Caused by the Administration of Trastuzumab plus Anastrozole for the Treatment of Inflammatory Breast Cancer]. ( Aizu, K; Fujieda, H; Furuta, M; Iwata, T; Kageyama, Y; Kobayashi, S; Sato, F; Toyoda, Y; Watanabe, S; Yamaguchi, R, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Iwata, T1
Yamaguchi, R1
Furuta, M1
Watanabe, S1
Aizu, K1
Kobayashi, S1
Sato, F1
Fujieda, H1
Toyoda, Y1
Kageyama, Y1

Other Studies

1 other study available for anastrozole and Diffuse Parenchymal Lung Disease

ArticleYear
[Case Report of an Elderly Patient with Interstitial Pneumonia Caused by the Administration of Trastuzumab plus Anastrozole for the Treatment of Inflammatory Breast Cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2021, Volume: 48, Issue:5

    Topics: Aged, 80 and over; Anastrozole; Female; Humans; Inflammatory Breast Neoplasms; Lung Diseases, Inters

2021